Skip to Main Content

ethics

Here’s the latest on ethics in medicine, science and technology. Topics include gene editing, artificial intelligence, the use of big data in health care, potential conflicts of interest and an array of moral quandaries.

Latest

Biotech Timmy Broderick

STAT Plus: Gene therapies for deafness dredge up an old question: Do deaf people want a ‘cure’?

In the Lab Mark Arsenault — Boston Globe

STAT Plus: Former MIT biologist David Sabatini, forced out after sexual harassment accusations, to lead new Boston team

First Opinion Casimir Klim

Lessons to psychiatrists-in-training from the CIA’s mind-control projects

Health tech Timmy Broderick

STAT Plus: The next frontier in data privacy? Your brain

Health Annalisa Merelli

New HHS guidance requires consent for pelvic, breast, and other sensitive examinations

In the Lab Nicholas St. Fleur

Q&A: Stem cell biologist predicts human embryo models could pave the way to organ transplants

First Opinion Joel B. Zivot

A new Louisiana capital-punishment bill would fundamentally alter physician licensing

First Opinion Christina S. Beck

How much personal health information does King Charles owe the public?

All Coverage

First Opinion Robert Klitzman

What the pope is missing about commercial surrogacy

In the Lab Mark Arsenault — Boston Globe

STAT Plus: Former MIT biologist, who lost positions after engaging in a prohibited sexual relationship, accepts new science position in Prague

advertisement

First Opinion Michael H. Bernstein and Grayson L. Baird

Phenylephrine is no better than a placebo. What if that’s still better than nothing?

Health tech Lizzy Lawrence

STAT Plus: Artificial wombs, after years in development, reach FDA review for human trials

First Opinion Gregory E. Kaebnick

The morally ground-shifting legacy of Ian Wilmut and Dolly the sheep

Health Theresa Gaffney

Randomized controlled trials are the ‘gold standard’ of research — but a difficult fit for trans care

In the Lab Megan Molteni

New definition of a human embryo proposed amid rapid scientific advances

In the Lab Megan Molteni

STAT Plus: Global controversy heats up the race to build human embryo models from stem cells

First Opinion Arthur L. Caplan

STAT Plus: How I helped Pfizer think through the ethics of Viagra 25 years ago

First Opinion Eric D. Perakslis, Katie D. McMillan, and Jessilyn Dunn

Proposed rules to protect health data in an era of abortion bans fall short

First Opinion Noura Abul-Husn

Why the rise of DNA testing is creating challenges — and an opportunity

First Opinion Martha Gershun

Living kidney donors rely on a promise to protect our future health. We’re scared it will go away

First Opinion Sam Weiss Evans and David Gillum

The lab leak conversation shows it’s time to rethink our biosecurity infrastructure, not just policies

In the Lab Megan Molteni

Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed

In the Lab Megan Molteni

STAT Plus: Mice with two fathers and base-edited baby monkeys highlight potential — and limitations — of hereditable gene editing

In the Lab Megan Molteni

STAT Plus: Ahead of genome summit in London, questions linger about CRISPR baby scandal

In the Lab Jonathan Wosen

‘It is a balance’: Scientists grapple with ethics of cutting-edge stem cell research

Health Amanda Seitz — Associated Press

U.S. plans crackdown on nursing homes that sedate patients with unnecessary antipsychotics

Health Adam Beam — Associated Press

California’s dark history of forced sterilizations comes into focus as it seeks victims to pay reparations

Health Usha Lee McFarling

Paying research participants — a lot — may be a key to increasing diversity in studies

In the Lab Andrew Joseph

Science, Cell issue notices of concern on challenged papers co-authored by Stanford president